FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

434337009: Fosaprepitant dimeglumine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2742660010 Fosaprepitant dimeglumine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2770654011 Fosaprepitant dimeglumine en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fosaprepitant dimeglumine Is a Fosaprepitant false Inferred relationship Existential restriction modifier
Fosaprepitant dimeglumine Has disposition Neurokinin 1 receptor antagonist true Inferred relationship Existential restriction modifier
Fosaprepitant dimeglumine Is a Triazole derivative false Inferred relationship Existential restriction modifier
Fosaprepitant dimeglumine Is modification of Fosaprepitant true Inferred relationship Existential restriction modifier
Fosaprepitant dimeglumine Is a Substance with receptor antagonist mechanism of action (substance) false Inferred relationship Existential restriction modifier
Fosaprepitant dimeglumine Is a Substance with neurokinin 1 receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Fosaprepitant dimeglumine Is a Substance with triazole structure true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Fosaprepitant 115mg powder for injection solution 10mL vial Has active ingredient False Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for injection Has precise active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier 1
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 150 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier 1
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier 1
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier 1
Fosaprepitant 115mg powder for solution for injection vials Has active ingredient False Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Ivemend 115mg powder for solution for infusion vials (Organon Pharma (UK) Ltd) Has active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Fosaprepitant 115mg powder for solution for injection vials 1 vial Has active ingredient False Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Ivemend 115mg powder for solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial Has active ingredient False Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Ivemend 115mg powder for solution for infusion vials (Organon Pharma (UK) Ltd) Has specific active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Fosaprepitant 115mg powder for injection solution 10mL vial Has specific active ingredient False Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Ivemend 115mg powder for solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Fosaprepitant 115mg powder for solution for injection vials 1 vial Has specific active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Fosaprepitant 150mg powder for solution for infusion vials Has specific active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Ivemend 150mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Fosaprepitant 150mg powder for solution for infusion vials 1 vial Has specific active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Ivemend 150mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial Has specific active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Fosaprepitant 115mg powder for solution for infusion vials Has specific active ingredient False Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier
Fosaprepitant 115mg powder for solution for infusion vials Has specific active ingredient True Fosaprepitant dimeglumine Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start